Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 106
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Biotechnol Appl Biochem ; 68(3): 585-596, 2021 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-32497351

RESUMO

Biosurfactants are microbial surface-active compounds with antimicrobial and antioxidant activities that display a range of physiological functions. In this study, a strain isolated from a Cameroonian fermented milk "pendidam" and identified as Lactobacillus casei subsp. casei TM1B was used for biosurfactants production. The biosurfactants produced by L. casei TM1B with molasses as the substrate had a good surface (40.77 mN/m) and emulsifying (84.50%) activities. The scavenging of the ABTS+• radical (IC50 value of 0.60 ± 0.03 mg/mL) by the biosurfactants was found to be higher than that of DPPH• radical (IC50 value of 0.97 ± 0.13 mg/mL). The maximum chelating activity of biosurfactants (82.29%) was observed at 3.5 mg/mL. The biologically active compound of the biosurfactants produced by L. casei TM1B was identified as 2,5-O-methylrhamnofuranosyl-palmitate, a novel rhamnolipid-like biosurfactant by using chemical, Fourier transform infrared spectroscopy, gas chromatography-mass spectrometry, and NMR analysis. The biosurfactants were bactericidal against several Gram-negative and Gram-positive pathogens (minimum inhibitory concentration values ranged from 3.22 to 12.83 mg/mL), and scanning electron microscope analysis revealed bacterial cell walls and membranes as main targets.


Assuntos
Antibacterianos/farmacologia , Antioxidantes/farmacologia , Bactérias Gram-Negativas/efeitos dos fármacos , Bactérias Gram-Positivas/efeitos dos fármacos , Lacticaseibacillus casei/química , Tensoativos/farmacologia , Antibacterianos/química , Antibacterianos/metabolismo , Antioxidantes/química , Antioxidantes/metabolismo , Benzotiazóis/antagonistas & inibidores , Compostos de Bifenilo/antagonistas & inibidores , Lacticaseibacillus casei/enzimologia , Lacticaseibacillus casei/isolamento & purificação , Testes de Sensibilidade Microbiana , Melaço , Picratos/antagonistas & inibidores , Ácidos Sulfônicos/antagonistas & inibidores , Tensoativos/química , Tensoativos/metabolismo
2.
Clin Exp Immunol ; 199(3): 303-313, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-31758701

RESUMO

Kawasaki disease (KD) is the leading cause of acquired heart disease in children. In addition to coronary artery abnormalities, aneurysms and myocarditis, acute KD is also associated with echocardiogram (ECG) abnormalities in 40-80% of patients. Here, we show that these ECG changes are recapitulated in the Lactobacillus casei cell wall extract (LCWE)-induced KD vasculitis mouse model. LCWE-injected mice developed elevated heart rate and decreased R wave amplitude, with significant differences in prolonged ventricular repolarization. LCWE-injected mice developed cardiac ganglion inflammation, that may affect the impulse-conducting system in the myocardium. Furthermore, serum nerve growth factor (NGF) was significantly elevated in LCWE-injected mice, similar to children with KD vasculitis, associated with increased neural remodeling of the myocardium. ECG abnormalities were prevented by blocking interleukin (IL)-1 signaling with anakinra, and the increase in serum NGF and cardiac neural remodeling were similarly blocked in Il1r1-/- mice and in wild-type mice treated with anakinra. Thus, similar to clinical KD, the LCWE-induced KD vasculitis mouse model also exhibits electrophysiological abnormalities and cardiac neuronal remodeling, and these changes can be prevented by blocking IL-1 signaling. These data support the acceleration of anti-IL-1 therapy trials to benefit KD patients.


Assuntos
Modelos Animais de Doenças , Interleucina-1/metabolismo , Síndrome de Linfonodos Mucocutâneos/fisiopatologia , Vasculite/fisiopatologia , Animais , Antirreumáticos/farmacologia , Produtos Biológicos/toxicidade , Parede Celular/química , Criança , Eletrocardiografia/efeitos dos fármacos , Feminino , Humanos , Proteína Antagonista do Receptor de Interleucina 1/farmacologia , Interleucina-1/genética , Lacticaseibacillus casei/química , Camundongos Endogâmicos C57BL , Camundongos Knockout , Síndrome de Linfonodos Mucocutâneos/induzido quimicamente , Síndrome de Linfonodos Mucocutâneos/terapia , Fator de Crescimento Neural/sangue , Receptores Tipo I de Interleucina-1/genética , Receptores Tipo I de Interleucina-1/metabolismo , Transdução de Sinais/efeitos dos fármacos , Vasculite/induzido quimicamente , Vasculite/terapia
3.
Biosci Biotechnol Biochem ; 84(8): 1529-1540, 2020 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-32434433

RESUMO

Biomineralization by living organisms are common phenomena observed everywhere. Molluskan shells are representative biominerals that have fine microstructures with controlled morphology, polymorph, and orientation of CaCO3 crystals. A few organic molecules involved in the biominerals play important roles in the formation of such microstructures. Analyses of structure-function relationships for matrix proteins in biominerals revealed that almost all matrix proteins have an acidic region for the binding of calcium ion in CaCO3 crystals and interaction domains for other organic molecules. On the other hand, biomineralization of metal nanoparticles by microorganisms were also investigated. Gold nanoparticles and quantum dots containing cadmium were successfully synthesized by bacteria or a fungus. The analyses of components revealed that glycolipids, oligosaccharides, and lactic acids have key roles to synthesize the gold nanoparticle in Lactobacillus casei as reductants and dispersants. These researches about biomineralization will give new insights for material and environmental sciences in the human society.


Assuntos
Exoesqueleto/metabolismo , Biomineralização/fisiologia , Quitina/química , Proteínas da Matriz Extracelular/química , Nanopartículas Metálicas/química , Exoesqueleto/química , Exoesqueleto/ultraestrutura , Animais , Quitina/metabolismo , Quitina/ultraestrutura , Proteínas da Matriz Extracelular/metabolismo , Proteínas da Matriz Extracelular/ultraestrutura , Fusarium/química , Fusarium/fisiologia , Humanos , Lacticaseibacillus casei/química , Lacticaseibacillus casei/fisiologia , Nanopartículas Metálicas/ultraestrutura , Pinctada/anatomia & histologia , Pinctada/fisiologia , Especificidade da Espécie
4.
Int J Vitam Nutr Res ; 88(3-4): 199-208, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-31056010

RESUMO

Aflatoxin B1(AFB1) is a toxic compound commonly found in some crops with an adverse health effect on human and animals. Some beneficial microorganisms (or probiotics) such as lactic acid bacteria have shown the ability to reduce the bioavailability of aflatoxins and its intestinal absorption. However, the dose and duration of aflatoxins exposure and probiotic treatment can influence the ability of probiotics to remove aflatoxins. Therefore, this research aimed to investigate the efficacy of oral probiotic Lactobacillus casei Shirota strain (LcS) induction in an acute exposure to AFB1 in rats. Experimentally, Sprague Dawley rats were divided into three groups: AFB1 only (n = 9); AFB1 treated with LcS (n = 9); and control (no AFB1 exposure) (n = 6) groups. The blood AFB1 level of rats treated with LcS was slightly lower than the untreated AFB1 induced rats (11.12 ± 0.71 vs 10.93 ± 0.69 ng g-1). Also, LcS treatment slightly moderated the liver and kidney biomarkers in AFB1 induced rats. However, a trend for a significant difference was only observed in ALT of AFB1 induced rats treated with LcS compared to their counterparts (126.11 ± 36.90 vs 157.36 ± 15.46, p = 0.06). Rats' body weight decreased in all animals force-fed with AFB1 with no significant difference between LcS treatment compared to the counterpart. In conclusion, this experiment indicated that probiotic LsC was able to slightly ameliorate the adverse effect of an acute exposure to AFB1 in rats. However, future studies with longer probiotics treatment or higher probiotics dose is required to confirm these findings.


Assuntos
Aflatoxinas , Lacticaseibacillus casei , Probióticos , Administração Oral , Aflatoxinas/efeitos adversos , Animais , Humanos , Lacticaseibacillus casei/química , Ratos , Ratos Sprague-Dawley
5.
Pol J Microbiol ; 67(3): 273-281, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30451443

RESUMO

Probiotics promote and help to maintain beneficial microbiota composition of the gastrointestinal tract ecosystem and have a positive impact on the host's health. Production of exopolysaccharides is an important feature of probiotic lactobacilli. It increases the chance of their survival in the gastrointestinal tract and promotes adhesion to the epithelium; therefore, exopolysaccharides are important for the process of colonization. Two lactic acid bacteria strains were used in this study: Lactobacillus rhamnosus KL 53A and Lactobacillus casei Fyos. Exopolysaccharides were isolated from bacterial cells and their monosaccharide composition was examined using liquid chromatography. The influence of exopolysaccharides on lactobacilli adhesion to enterocytes was studied after deglycosylation of the bacterial cells and incubation with the selected intestinal microbiota strains that metabolize polysaccharides - Faecalibacterium prausnitzii DSM 17677 and Blautia luti DSM 14534. Both deglycosylation and incubation with polysaccharide metabolizing strains influenced the ability of probiotic strains to adhere to enterocytes. Enzymatic deglycosylation decreased adhesion efficiency of L. rhamnosus KL 53A; however, co-incubation of both lactobacillus strains with F. prausnitzii DSM 17677 resulted in an increase of their adhesion efficiency. Exopolysaccharides are important adhesins of Lactobacillus spp. that influence their ability to colonize gut epithelium. Other members of gut microbiota can modify the adhesion property in situ ; therefore the composition and metabolic state of commensal bacteria may influence their probiotic action.


Assuntos
Aderência Bacteriana , Enterócitos/microbiologia , Lacticaseibacillus casei/química , Lacticaseibacillus rhamnosus/química , Polissacarídeos Bacterianos/metabolismo , Células CACO-2 , Faecalibacterium/enzimologia , Microbioma Gastrointestinal , Humanos , Hidrólise , Lacticaseibacillus casei/fisiologia , Lacticaseibacillus rhamnosus/fisiologia , Probióticos
6.
Tumour Biol ; 39(6): 1010428317711311, 2017 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-28639907

RESUMO

Ferrichrome is known to be a siderophore, but it was recently identified as a tumor-suppressive molecule derived from Lactobacillus casei ATCC334 ( L. casei). In the present study, we investigated the effects of ferrichrome in gastric cancer cells. Cell lines and xenograft models treated with ferrichrome demonstrated growth suppression. The expression levels of cleaved poly (adenosine diphosphate-ribose) polymerase, and cleaved caspase-9 were increased by ferrichrome treatment. Although the tumor-suppressive effects of ferrichrome were almost completely diminished by the iron chelation, the reduction in the intracellular iron by ferrichrome did not correlate with its tumor-suppressive effects. An exhaustive docking simulation indicated that iron-free ferrichrome can make stable conformations with various mammalian molecules, including transporters and receptors. In conclusion, probiotic-derived ferrichrome induced apoptosis in gastric cancer cells. The iron binding site of ferrichrome is the structure responsible for its tumor suppressive function.


Assuntos
Apoptose/efeitos dos fármacos , Ferricromo/administração & dosagem , Ferricromo/química , Neoplasias Gástricas/tratamento farmacológico , Animais , Sítios de Ligação , Caspase 9/biossíntese , Linhagem Celular Tumoral , Ferricromo/isolamento & purificação , Humanos , Ferro/metabolismo , Lacticaseibacillus casei/química , Camundongos , Simulação de Acoplamento Molecular , Neoplasias Gástricas/patologia , Ensaios Antitumorais Modelo de Xenoenxerto
7.
Fish Shellfish Immunol ; 67: 441-448, 2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-28602743

RESUMO

The present study was performed to investigate the immunomodulatory and health promoting effects of combined or singular administration of apple cider vinegar (ACV) and Lactobacillus casei in common carp (Cyprinus carpio) diet. An 8-week feeding trial was designed with following treatments: Control (basal diet), Pro (contains 107 CFU g-1L. casei), LACV (contains 1% ACV), HACV (contains 2% ACV), Pro + LACV (contains 107 CFU g-1L. casei plus 1% ACV) and Pro + HACV (contains 107 CFU g-1L. casei plus 2% ACV). Evaluation of skin mucus revealed notable increase of total Ig level and lysozyme activity in Pro + LACV and Pro + HACV treatments compared other groups (P < 0.05). Similarly, serum total Ig and lysozyme activity in HACV, Pro + LACV and Pro + HACV fed carps was remarkably higher than other groups (P < 0.05). However, regarding serum alternative complement (ACH50) activity significant difference was observed just between Pro + HACV and control treatment (P < 0.05). The highest expression of immune related (LYZ, TNF-alpha, IL1b, IL8) and antioxidant enzymes genes (GSR, GST) were observed in carps fed Pro + HACV and Pro + LACV. The expression of GH gene expression in Pro, LACV and HACV treatments was significantly higher than those in control group (P < 0.05). The highest expression level of GH and IGF1 was observed in fish fed combined Pro and ACV (P < 0.05). These results indicated that co-administration of ACV boosted immunomodulatory and health promoting effects of L. casei and can be considered as a promising immunostimulants in early stage of common carp culture.


Assuntos
Ácido Acético/química , Carpas/fisiologia , Imunidade nas Mucosas , Imunomodulação , Lacticaseibacillus casei/química , Malus/química , Probióticos/administração & dosagem , Ração Animal/análise , Animais , Carpas/genética , Carpas/crescimento & desenvolvimento , Carpas/imunologia , Dieta , Distribuição Aleatória
8.
Biologicals ; 45: 47-51, 2017 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-27816388

RESUMO

There are few practical protocols to extract efficient plasmid DNA from the difficult-to-lyse bacterium, Lactobacillus casei. This is related to production of a large amount of exopolysaccharide coat and its special physiological characteristics. In this study, we optimized a protocol to extract efficient plasmid DNA from a recombinant L. casei strain. Different extraction methods were evaluated in three classes of conventional, kit-based, and combined protocols. The quantity and quality of the extracted plasmid DNA were determined by spectrophotometry, agarose gel electrophoresis, and PCR. Results revealed that the yield of the extracted plasmids differed for each protocol and conventional protocols showed higher plasmid yields. We suggested an effective, inexpensive protocol to extract plasmid DNA from the recombinant L. casei for downstream biological processes.


Assuntos
DNA Bacteriano/isolamento & purificação , Lacticaseibacillus casei/química , Plasmídeos/isolamento & purificação , DNA Bacteriano/química , Plasmídeos/química
9.
Adv Exp Med Biol ; 925: 117-145, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-27815924

RESUMO

Many bacterial L-lactate dehydrogenases (LDH) are allosteric enzymes, and usually activated by fructose 1,6-bisphosphate (FBP) and often also by substrate pyruvate. The active and inactive state structures demonstrate that Thermus caldophilus, Lactobacillus casei, and Bifidobacterium longum LDHs consistently undergo allosteric transition according to Monod-Wyman-Changeux model, where the active (R) and inactive (T) states of the enzymes coexist in an allosteric equilibrium (pre-existing equilibrium) independently of allosteric effectors. The three enzymes consistently take on open and closed conformations of the homotetramers for the T and R states, coupling the quaternary structural changes with the structural changes in binding sites for substrate and FBP though tertiary structural changes. Nevertheless, the three enzymes undergo markedly different structural changes from one another, indicating that there is a high variety in the allosteric machineries of bacterial LDHs. L. casei LDH undergoes the largest quaternary structural change in the three enzymes, and regulates its catalytic activity though a large linkage frame for allosteric motion. In contrast, T. caldophilus LDH exhibits the simplest allosteric motion in the three enzymes, involving a simple mobile structural core for the allosteric motion. TcLDH likely mediates its allosteric equilibrium mostly through electrostatic repulsion within the protein molecule, providing an insight for regulation machineries in bacterial allosteric LDHs.


Assuntos
Proteínas de Bactérias/química , Bifidobacterium longum/enzimologia , Frutosedifosfatos/química , L-Lactato Desidrogenase/química , Lacticaseibacillus casei/enzimologia , Ácido Pirúvico/química , Thermus/enzimologia , Regulação Alostérica , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , Bifidobacterium longum/química , Bifidobacterium longum/genética , Sítios de Ligação , Frutosedifosfatos/metabolismo , Expressão Gênica , Cinética , L-Lactato Desidrogenase/genética , L-Lactato Desidrogenase/metabolismo , Lacticaseibacillus casei/química , Lacticaseibacillus casei/genética , Modelos Moleculares , Ligação Proteica , Domínios e Motivos de Interação entre Proteínas , Estrutura Quaternária de Proteína , Subunidades Proteicas/química , Subunidades Proteicas/genética , Subunidades Proteicas/metabolismo , Ácido Pirúvico/metabolismo , Especificidade da Espécie , Relação Estrutura-Atividade , Especificidade por Substrato , Thermus/química , Thermus/genética
10.
Glycobiology ; 26(9): 1014-1024, 2016 09.
Artigo em Inglês | MEDLINE | ID: mdl-27102285

RESUMO

The Lactobacillus casei strain, LOCK 0919, is intended for the dietary management of food allergies and atopic dermatitis (LATOPIC® BIOMED). The use of a probiotic to modulate immune responses is an interesting strategy for solving imbalance problems of gut microflora that may lead to various disorders. However, the exact bacterial signaling mechanisms underlying such modulations are still far from being understood. Here, we investigated variations in the chemical compositions and immunomodulatory properties of the polysaccharides (PS), L919/A and L919/B, which are produced by L. casei LOCK 0919. By virtue of their chemical features, such PS can modulate the immune responses to third-party antigens. Our results revealed that L919/A and L919/B could both modulate the immune response to Lactobacillus planatarum WCFS1, but only L919/B could alter the response of THP-1 cells (in terms of tumor necrosis factor alpha production) to L. planatarum WCFS1 and Escherichia coli Nissle 1917. The comprehensive immunochemical characterization is crucial for the understanding of the biological function as well as of the bacteria-host and bacteria-bacteria cross-talk.


Assuntos
Fatores Imunológicos/química , Lacticaseibacillus casei/química , Polissacarídeos/química , Escherichia coli/imunologia , Humanos , Imunidade Celular/efeitos dos fármacos , Fatores Imunológicos/imunologia , Fatores Imunológicos/uso terapêutico , Lacticaseibacillus casei/imunologia , Polissacarídeos/imunologia , Probióticos/uso terapêutico
11.
Anticancer Drugs ; 27(7): 609-19, 2016 08.
Artigo em Inglês | MEDLINE | ID: mdl-27101258

RESUMO

In a previous study, we reported the cytotoxic activity against various tumour cells of the peptidoglycan of Lactobacillus casei. To isolate the most active components, we performed column-chromatography separation of the peptidoglycan complex and tested the related fractions for their cytotoxic activity. The most active fractions were then lyophilized and the residue was analysed by gas chromatography for its amino acid content and composition. On the basis of the known chemical formula of the basic peptidic component of the peptidoglycan complex of L. casei, a peptide was then synthesized [Europ. (CH-DE-FR-GB) Patent number 1217005; IT number 01320177] and its cytotoxicity was tested against tumoural and normal cells. The synthetic peptide was found to impair the entire metabolism of cultured tumour cells and to restore the apoptotic process. By contrast, normal cells appeared to be stimulated rather than inhibited by the peptide, whereas primary mouse embryo fibroblasts behaved similarly to tumour cells. On the basis of these results, L. casei peptidoglycan fragments and their constituent basic peptide might be applicable as potent antitumour agents.


Assuntos
Hexoquinase/metabolismo , Lacticaseibacillus casei/química , Mitocôndrias/enzimologia , Neoplasias/tratamento farmacológico , Fragmentos de Peptídeos/isolamento & purificação , Fragmentos de Peptídeos/farmacologia , Peptidoglicano/química , Animais , Antineoplásicos/síntese química , Antineoplásicos/isolamento & purificação , Antineoplásicos/farmacologia , Humanos , Células K562 , Masculino , Camundongos , Mitocôndrias/efeitos dos fármacos , Fragmentos de Peptídeos/síntese química , Peptidoglicano/farmacologia , Ratos , Hipóxia Tumoral
12.
Food Microbiol ; 60: 54-61, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27554146

RESUMO

In previous work, we demonstrated that two probiotic strains, namely Lactobacillus casei PRA205 and Lactobacillus rhamnosus PRA331, produce fermented milks with potent angiotensin-converting enzyme (ACE)-inhibitory and antioxidant activities. Here, we tested these strains for the survivability and the release of antihypertensive and antioxidant peptides in yogurt fermentation and cold storage. For these purposes three yogurt batches were compared: one prepared using yogurt starters alone (Lactobacillus delbrueckii subspecies bulgaricus 1932 and Streptococcus thermophilus 99), and the remaining two containing either PRA205 or PRA331 in addition to yogurt starters. Despite the lower viable counts at the fermentation end compared to PRA331, PRA205 overcame PRA331 in survivability during refrigerated storage for 28 days, leading to viable counts (>10(8) CFU/g) higher than the minimum therapeutic threshold (10(6) CFU/g). Analyses of in vitro ACE-inhibitory and antioxidant activities of peptide fractions revealed that yogurt supplemented with PRA205 displays higher amounts of antihypertensive and antioxidant peptides than that produced with PRA331 at the end of fermentation and over storage. Two ACE-inhibitory peptides, Valine-Proline-Proline (VPP) and Isoleucine-Proline-Proline (IPP), were identified and quantified. This study demonstrated that L. casei PRA205 could be used as adjunct culture for producing bi-functional yogurt enriched in bioactive peptides and in viable cells, which bring health benefits to the host as probiotics.


Assuntos
Temperatura Baixa , Fermentação , Armazenamento de Alimentos , Viabilidade Microbiana , Probióticos/metabolismo , Iogurte/análise , Iogurte/microbiologia , Inibidores da Enzima Conversora de Angiotensina/análise , Animais , Antioxidantes , Produtos Fermentados do Leite/análise , Produtos Fermentados do Leite/microbiologia , Produtos Fermentados do Leite/normas , Lacticaseibacillus casei/química , Lacticaseibacillus casei/crescimento & desenvolvimento , Lacticaseibacillus casei/fisiologia , Lacticaseibacillus rhamnosus/química , Lacticaseibacillus rhamnosus/crescimento & desenvolvimento , Lacticaseibacillus rhamnosus/fisiologia , Leite/microbiologia , Oligopeptídeos/análise , Biossíntese Peptídica , Probióticos/química , Streptococcus thermophilus/química , Streptococcus thermophilus/fisiologia
13.
J Dairy Sci ; 99(1): 18-30, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26519974

RESUMO

In this study, the addition of Lactobacillus casei Zhang in the manufacture of Minas Frescal cheese was investigated. Minas Frescal cheeses supplemented with probiotic bacteria (Lactobacillus casei Zhang) were produced by enzymatic coagulation and direct acidification and were subjected to physicochemical (pH, proteolysis, lactic acid, and acetic acid), microbiological (probiotic and lactic bacteria counts), and rheological analyses (uniaxial compression and creep test), instrumental color determination (luminosity, yellow intensity, and red intensity) and sensory acceptance test. The addition of L. casei Zhang resulted in low pH values and high proteolysis indexes during storage (from 5.38 to 4.94 and 0.470 to 0.702, respectively). Additionally, the cheese protocol was not a hurdle for growth of L. casei Zhang, as the population reached 8.16 and 9.02 log cfu/g by means of the direct acidification and enzymatic coagulation protocol, respectively, after 21 d of refrigerated storage. The rheology data showed that all samples presented a more viscous-like behavior, which rigidity tended to decrease during storage and lower luminosity values were also observed. Increased consumer acceptance was observed for the control sample produced by direct acidification (7.8), whereas the cheeses containing L. casei Zhang presented lower values for all sensory attributes, especially flavor and overall liking (5.37 and 4.61 for enzymatic coagulation and 5.57 and 4.72 for direct acidification, respectively). Overall, the addition of L. casei Zhang led to changes in all parameters and affected negatively the sensory acceptance. The optimization of L. casei Zhang dosage during the manufacturing of probiotic Minas Frescal cheese should be performed.


Assuntos
Queijo/análise , Qualidade dos Alimentos , Lacticaseibacillus casei/química , Probióticos/química , Carga Bacteriana
14.
Tumour Biol ; 36(5): 3775-89, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25557887

RESUMO

Ribosomal synthesized antimicrobial peptides (AMPs) are widely distributed in nature and are toxic to certain microorganisms. Some of these AMPs are found to exhibit cytotoxic activity against the growth of cancer cells and thus have obvious anticancer potential. Here, we have studied the antiproliferation on the human colorectal cancer cell line SW480 of two AMPs, namely m2163 and m2386, identified by us from a lactic acid bacterium Lactobacillus casei ATCC 334 previously. A half maximal inhibitory concentration (IC50) of 40 µg/ml is determined first using the MTT (3-(4, 5-cimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay for either peptide m2163 or m2386. The apoptosis in treated SW480 cells by either peptide m2163 or m2386 is analyzed using flow cytometry with annexin V-fluorescein isothiocyanate (FITC) and propidium iodide double staining. These analyses show that a substantial population of treated SW480 cells can undergo apoptosis by either peptide m2163 or m2386. The real-time quantitative polymerase chain reaction (qPCR) and Western blot analyses are subsequently used to study how the apoptosis is induced in the treated SW480 cells by either peptide m2163 or m2386. While m2163 is found to induce the expression of Fas and TRAILR1, the expression of Fas, TNFR1, and TRAILR1 death receptors on the cell surface of treated SW480 cells is found to be induced by m2386. Further, the expression of some mitochondria-related apoptosis proteins such as Smac is found to be also induced, suggesting that either peptide m2163 or m2386 can trigger both the extrinsic and intrinsic apoptosis pathways. The cell membrane permeability is greatly enhanced upon treatment with either peptide m2163 or m2386 as analyzed by the flow cytometry using both FITC-labeled peptides. The flow cytometry is also used to analyze the fluorescence intensity given by FITC-m2163 in either the mitochondria or cytoplasm fraction of the treated and fractionated SW480 cells. It is found that the detected fluorescence intensity of the mitochondria fraction is much weaker than that of the cytoplasm one, suggesting that most of the FITC-m2163 peptides are located in the cytoplasm rather than the mitochondria. This is further confirmed by a confocal microscopy study that either peptide m2163 or m2386 can localize on the cell membrane for a substantial length of time and then penetrate into the cell cytoplasm to induce the apoptosis.


Assuntos
Peptídeos Catiônicos Antimicrobianos/administração & dosagem , Apoptose/efeitos dos fármacos , Proteínas de Bactérias/administração & dosagem , Proliferação de Células/efeitos dos fármacos , Neoplasias Colorretais/tratamento farmacológico , Peptídeos/administração & dosagem , Linhagem Celular Tumoral , Neoplasias Colorretais/patologia , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Humanos , Lacticaseibacillus casei/química , Microscopia Confocal , Mitocôndrias/efeitos dos fármacos , Proteínas de Neoplasias/biossíntese , Ribossomos/química
15.
Appl Microbiol Biotechnol ; 99(17): 7089-99, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-25687448

RESUMO

Atopic dermatitis (AD) is a chronic inflammatory skin disease, with a complex etiology encompassing immunologic responses. AD is frequently associated with elevated serum immunoglobulin (Ig) E levels and is exacerbated by a variety of environmental factors, which contribute to its pathogenesis. However, the etiology of AD remains unknown. Recently, reports have documented the role of lactic acid bacteria (LAB) in the treatment and prevention of AD in humans and mice. The LAB, Lactobacillus casei (LC), is frequently used in the treatment of AD. To identify the active component of LC, we screened fractions obtained from the ion exchange chromatography of LC extracts. Using this approach, we identified the candidate protein, P14. We examined whether the P14 protein has anti-atopic properties, using both in vitro and in vivo models. Our results showed that the P14 protein selectively downregulated serum IgE and interleukin-4 cytokine levels, as well as the AD index and scratching score in AD-like NC/Nga mice. In addition, histological examination was also effective in mice. These results suggest that the P14 protein has potential therapeutic effects and that it may also serve as an effective immunomodulatory agent for treating patients with AD.


Assuntos
Proteínas de Bactérias/administração & dosagem , Dermatite Atópica/terapia , Fatores Imunológicos/administração & dosagem , Interleucina-4/antagonistas & inibidores , Lacticaseibacillus casei/química , Macrófagos/imunologia , Pele/patologia , Animais , Proteínas de Bactérias/isolamento & purificação , Proteínas de Bactérias/farmacologia , Dermatite Atópica/patologia , Histocitoquímica , Fatores Imunológicos/isolamento & purificação , Fatores Imunológicos/farmacologia , Camundongos , Células RAW 264.7 , Índice de Gravidade de Doença , Resultado do Tratamento
16.
Microbiol Immunol ; 58(10): 559-69, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-25130071

RESUMO

Probiotics, defined as living bacteria that are beneficial for human health, mainly function through their immunomodulatory abilities. Hence, these microorganisms have proven successful for treating diseases resulting from immune deregulation. The aim of this study was to find novel candidates to improve on and complement current probiotic treatment strategies. Of 60 lactic acid bacterial strains that were isolated from fecal samples of healthy, full-term, breast-fed infants, three were chosen because of their ability to activate human immune cells. These candidates were then tested with regard to immunomodulatory properties, antimicrobial effects on pathogens, required pharmacological properties and their safety profiles. To identify the immunomodulatory structures of the selected isolates, activation of specific innate immune receptors was studied. The three candidates for probiotic treatment were assigned Enterococcus faecium NM113, Enterococcus faecium NM213 and Lactobacillus casei NM512. Compared with the established allergy-protective strain Lactococcus lactis G121, these isolates induced release of similar amounts of IL-12, a potent inducer of T helper 1 cells. In addition, all three neonatal isolates had antimicrobial activity against pathogens. Analysis of pharmacological suitability showed high tolerance of low pH, bile salts and pancreatic enzymes. In terms of safe application in humans, the isolates were sensitive to three antibiotics (chloramphenicol, tetracycline and erythromycin). In addition, the Enterococcus isolates were free from the four major virulence genes (cylA, agg, efaAfs and ccf). Moreover, the isolates strongly activated Toll-like receptor 2, which suggests lipopeptides as their active immunomodulatory structure. Thus, three novel bacterial strains with great potential as probiotic candidates and promising immunomodulatory properties have here been identified and characterized.


Assuntos
Enterococcus faecium/isolamento & purificação , Fezes/microbiologia , Fatores Imunológicos/isolamento & purificação , Lacticaseibacillus casei/isolamento & purificação , Probióticos/isolamento & purificação , Enterococcus faecium/química , Enterococcus faecium/genética , Enterococcus faecium/imunologia , Humanos , Interações Hidrofóbicas e Hidrofílicas , Fatores Imunológicos/química , Fatores Imunológicos/genética , Fatores Imunológicos/imunologia , Imunomodulação , Lactente , Recém-Nascido , Interleucina-12/imunologia , Lacticaseibacillus casei/química , Lacticaseibacillus casei/genética , Lacticaseibacillus casei/imunologia , Monócitos/imunologia , Monócitos/microbiologia , Probióticos/classificação
17.
Circ J ; 78(3): 752-62, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24334707

RESUMO

BACKGROUND: Vascular endothelial growth factor (VEGF) is associated with Kawasaki disease (KD), the most commonly acquired heart disease in developed countries. This study investigated the involvement of VEGF-A expression and its related signaling pathway in Lactobacillus casei cell wall extract (LCWE)-induced murine coronary artery lesions (CALs), and analyzed this in regard to the inhibition of CALs by spleen tyrosine kinase (Syk). METHODS AND RESULTS: Wild-type BALB/C mice were intraperitoneally injected with LCWE (1mg/ml) to induce CALs. The aortic roots, ventricular myocardium, peripheral blood leukocytes (PBLs), spleen, liver, kidneys, and lungs were analyzed for VEGF-A expression. Phosphate buffered saline (PBS)-, lipopolysaccharide (LPS)-, and zymosan-treated mice served as controls, and an oral Syk inhibitor served as an arteritis-ameliorated reagent. In aortic roots and PBLs, LCWE induced an early upregulation and a late downregulation of VEGF-A expression. No differential VEGF-A expression was observed in the other organs. Most importantly, Syk inhibition significantly attenuated the LCWE-induced expression of VEGF-A, dimethylarginine dimethylaminohydrolase (DDAH)-1, and endothelial nitric oxide synthase in aortic roots. However, LCWE-induced aortic DDAH-2 expression remained higher, despite Syk inhibition. CONCLUSIONS: Local VEGF-A and its signaling pathway are associated with the development of LCWE-induced CALs. Therefore, the clinical correlation between VEGF and human KD and the role of the VEGF-A regulation and signaling pathway in murine CALs warrant further investigation.


Assuntos
Arterite/metabolismo , Parede Celular/química , Misturas Complexas/toxicidade , Doença das Coronárias/metabolismo , Lacticaseibacillus casei/química , Síndrome de Linfonodos Mucocutâneos/metabolismo , Fator A de Crescimento do Endotélio Vascular/metabolismo , Animais , Aorta/metabolismo , Aorta/patologia , Arterite/induzido quimicamente , Misturas Complexas/química , Doença das Coronárias/congênito , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Síndrome de Linfonodos Mucocutâneos/patologia , Transdução de Sinais/efeitos dos fármacos
18.
J Appl Microbiol ; 116(5): 1250-61, 2014 May.
Artigo em Inglês | MEDLINE | ID: mdl-24506696

RESUMO

AIMS: To identify the differences that account for the acid sensitivity of Lactobacillus casei ΔRR12. RR12 controls the expression of the dlt operon, and its inactivation leads to a diminished teichoic acid D-alanylation activity. To this end, a comparison of its response of ΔRR12 to low pH with the parental strain Lact. casei BL23 was carried out. METHODS AND RESULTS: The ability to induce an acid tolerance response (ATR), fatty acid (FA) composition and proteome changes induced in both strains in response to acid were investigated. Results obtained showed that both strains induce a growth-phase-dependent ATR. However, significant differences in the content of FAs and membrane-associated proteins were detected. CONCLUSIONS: The greater abundance of cytoplasmic proteins in the membrane fraction of the mutant strain ΔRR12 suggests an increased permeability of the cell membrane in this strain. SIGNIFICANCE AND IMPACT OF THE STUDY: The analysis of the response to low pH of strain ΔRR12 indicated that the inactivation of TCS12 affected the content of FAs and proteins associated to the cell envelope. Increased abundance of cytoplasmic proteins suggested that low alanylation of teichoic acids affected the permeability of the cell membrane and possibly accounts for the acid sensitivity of strain ΔRR12.


Assuntos
Lacticaseibacillus casei/química , Proteínas de Bactérias/análise , Membrana Celular/química , Ácidos Graxos/análise , Concentração de Íons de Hidrogênio , Lacticaseibacillus casei/genética , Lacticaseibacillus casei/crescimento & desenvolvimento , Lacticaseibacillus casei/metabolismo , Proteínas de Membrana/análise , Mutação , Proteoma/química , Ácidos Teicoicos/metabolismo
19.
J Dairy Sci ; 97(7): 4062-71, 2014 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-24767886

RESUMO

Whey fermented liquid (WFL) was studied for its hepatoprotective effects by using chronic alcohol-induced mice. Whey fermented liquid, prepared by inoculating whey with 4% (vol/vol) Lactobacillus casei and then incubating at 41°C for 8h, was used to orally treat alcohol-induced mice at 3 dosages for 5 wk. Ethanol consumption significantly reduced the activity of superoxide dismutase and glutathione peroxidase, while lowering glutathione content and increasing levels of aspartate aminotransferase, alanine aminotransferase, total triglyceride, malondialdehyde, and cytochrome P450 2E1. Treatment with WFL significantly attenuated the increased levels of alanine aminotransferase, aspartate aminotransferase, triglyceride, and cytochrome P450 2E1, while decreasing superoxide dismutase, glutathione peroxidase, malondialdehyde, and glutathione levels. Pathological changes in the livers of mice who had ingested alcohol were improved by the administration of WFL. These results suggest that WFL may exert a protective effect against alcoholic liver disease by increasing antioxidant activity, which supports the use of WFL as an antialcoholic liver disease treatment.


Assuntos
Produtos Fermentados do Leite/microbiologia , Lacticaseibacillus casei/química , Hepatopatias Alcoólicas/tratamento farmacológico , Soro do Leite/metabolismo , Animais , Bovinos , DNA Bacteriano/genética , DNA Bacteriano/metabolismo , Relação Dose-Resposta a Droga , Fermentação , Lacticaseibacillus casei/classificação , Lacticaseibacillus casei/genética , Lacticaseibacillus casei/isolamento & purificação , Fígado/enzimologia , Camundongos , RNA Ribossômico 16S/genética , RNA Ribossômico 16S/metabolismo , Distribuição Aleatória , Soro do Leite/administração & dosagem
20.
J Microencapsul ; 31(8): 759-67, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25090592

RESUMO

This study evaluates the use of spray drying to produce microparticles of Lactobacillus casei. Microorganism was cultivated in shaken flasks and the microencapsulation process was performed using a laboratory-scale spray dryer. A rotational central composite design was employed to optimise the drying conditions. High cell viability (1.1 × 10(10) CFU/g) was achieved using an inlet air temperature of 70 °C and 25% (w/v) of maltodextrin. Microparticles presented values of solubility, wettability, water activity, hygroscopicity and humidity corresponding to 97.03 ± 0.04%, 100% (in 1.16 min), 0.14 ± 0.0, 35.20 g H2O/100 g and 4.80 ± 0.43%, respectively. The microparticles were spherical with a smooth surface and thermally stable. Encapsulation improved the survival of L. casei during storage. After 60 days, the samples stored at -8 °C showed viable cell concentrations of 1.0 × 10(9) CFU/g.


Assuntos
Lacticaseibacillus casei/química , Lacticaseibacillus casei/citologia , Cápsulas , Células Imobilizadas/química , Células Imobilizadas/citologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA